Conditional approvals

Shanghai Shenqi Medical Partners with Bio-heart to Commercialize BioHeart Bioresorbable Sirolimus‑Eluting Coronary Stent – Ultra‑Thin 90μm Strut Design Targets Deliverability and Radial Strength
CompanyDeals

Shanghai Shenqi Medical Partners with Bio-heart to Commercialize BioHeart Bioresorbable Sirolimus‑Eluting Coronary Stent – Ultra‑Thin 90μm Strut Design Targets Deliverability and Radial Strength

Shanghai Shenqi Medical Technology and Shanghai Bio‑heart Biological Technology (HKG: 2185) entered into a strategic partnership to jointly advance the commercialization and clinical application of Bio‑heart's proprietary BioHeart Bioresorbable Sirolimus‑Eluting…

HanX Biopharmaceuticals Signs Long‑Term Strategic Cooperation and AI Platform License with XtalPi Science – AI for Science to Power Antibody Design and Innovative Molecule Discovery

HanX Biopharmaceuticals Signs Long‑Term Strategic Cooperation and AI Platform License with XtalPi Science – AI for Science to Power Antibody Design and Innovative Molecule Discovery

AbbVie Taps Iambic's AI Platform in Multi-Year Collaboration – Enchant v3 Multimodal Model Targets First-in-Class Small Molecules in Immunology, Neuroscience and Oncology

AbbVie Taps Iambic’s AI Platform in Multi-Year Collaboration – Enchant v3 Multimodal Model Targets First-in-Class Small Molecules in Immunology, Neuroscience and Oncology

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Explore Now
CompanyDrug

Chipscreen Pharmaceutical’s Epidaza Granted Priority Status for DLBCL Treatment in China

CompanyDrug

CDE Indicates Priority Review for Overland ADCT’s Zynlonta and BeiGene’s Brukinsa

CompanyDrug

Roche’s Rozlytrek on Track for Priority Review for Pediatric NTRK Fusion Tumor Treatment

CompanyDrug

Bayer’s Copanlisib (Aliqopa) Approved by NMPA for Recurrent Follicular Lymphoma

CompanyDrug

TYK Medicines’ TY-9591 Gains CDE Green Light for Pivotal Phase II Study in NSCLC with Brain Metastases

CompanyDrug

Nanjing-Based Frontier Biotechnologies Secures Full Approval for Albuvirtide in China

CompanyDrug

Merck’s Lagevrio Receives Emergency Conditional Approval from China’s NMPA

Show More